Description

Kisqali is a medication used in the treatment of certain types of breast cancer, specifically hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer. It works by inhibiting specific proteins that promote cancer cell growth.

Interpreter Notes

Interpreters should be aware that Kisqali may be referred to by its generic name, ribociclib, in some contexts. It's important to maintain a formal register and ensure clarity when discussing this medication, as it may be confused with other cancer treatments. Stick to the term 'Kisqali' in formal medical discussions to avoid confusion.

Example Sentences

EN: The oncologist prescribed Kisqali as part of the treatment plan for the patient.

ES: El oncólogo recetó Kisqali como parte del plan de tratamiento para el paciente.

Common Interpreter Mistakes

Confusing Kisqali with other similar cancer medications; mispronouncing Kisqali as if it were a different drug; using informal language when discussing the medication.